Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. Dezember 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax Appoints Mark Twyman Vice President Marketing

GAITHERSBURG, Md., Dec. 21, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
14. Dezember 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

GAITHERSBURG, Md., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
08. Dezember 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax to Participate in the Guggenheim Securities 3rd Annual Boston Healthcare Conference

GAITHERSBURG, Md., Dec. 08, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
03. Dezember 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax Initiates Global Pivotal Phase 3 Trial of the RSV F Vaccine to Protect Infants via Maternal Immunization

GAITHERSBURG, Md., Dec. 03, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
24. November 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference

GAITHERSBURG, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
16. November 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax to Make Multiple Presentations at RSV Vaccines for the World

GAITHERSBURG, Md., Nov. 16, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
10. November 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax to Present at the Stifel 2015 Healthcare Conference

GAITHERSBURG, Md., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
09. November 2015 06:55 ET | Quelle: Novavax, Inc.

Novavax Reports Third Quarter 2015 Financial Results

GAITHERSBURG, Md., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
09. November 2015 06:50 ET | Quelle: Novavax, Inc.

Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults

GAITHERSBURG, Md., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...
02. November 2015 16:05 ET | Quelle: Novavax, Inc.

Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015

GAITHERSBURG, Md., Nov. 02, 2015 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant...

Vorherige Seite

Nächste Seite